US Bancorp’s Novartis NVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $41.1M | Sell |
262,178
-6,680
| -2% | -$1M | 0.04% | 225 |
|
|
2026
Q1 | $41.1M | Buy |
268,858
+1,589
| +0.6% | +$244K | 0.05% | 221 |
|
|
2025
Q4 | $36.8M | Buy |
267,269
+13,012
| +5% | +$1.7M | 0.04% | 234 |
|
|
2025
Q3 | $32.6M | Buy |
254,257
+31,197
| +14% | +$3.81M | 0.04% | 258 |
|
|
2025
Q2 | $27M | Sell |
223,060
-22,670
| -9% | -$2.56M | 0.03% | 277 |
|
|
2025
Q1 | $27.4M | Sell |
245,730
-2,810
| -1% | -$299K | 0.04% | 272 |
|
|
2024
Q4 | $24.2M | Buy |
248,540
+5,913
| +2% | +$631K | 0.03% | 285 |
|
|
2024
Q3 | $27.9M | Buy |
242,627
+26,150
| +12% | +$2.97M | 0.04% | 270 |
|
|
2024
Q2 | $23M | Sell |
216,477
-47,599
| -18% | -$4.78M | 0.03% | 278 |
|
|
2024
Q1 | $25.5M | Sell |
264,076
-2,467
| -0.9% | -$253K | 0.04% | 275 |
|
|
2023
Q4 | $26.9M | Buy |
266,543
+31,452
| +13% | +$3.04M | 0.04% | 259 |
|
|
2023
Q3 | $23.9M | Buy |
235,091
+26,946
| +13% | +$2.74M | 0.04% | 267 |
|
|
2023
Q2 | $21M | Buy |
208,145
+3,527
| +2% | +$353K | 0.03% | 286 |
|
|
2023
Q1 | $18.8M | Sell |
204,618
-27,261
| -12% | -$2.38M | 0.03% | 293 |
|
|
2022
Q4 | $21M | Buy |
231,879
+40,537
| +21% | +$3.41M | 0.04% | 278 |
|
|
2022
Q3 | $14.5M | Sell |
191,342
-66,954
| -26% | -$5.55M | 0.03% | 302 |
|
|
2022
Q2 | $21.8M | Buy |
258,296
+21,434
| +9% | +$1.88M | 0.04% | 251 |
|
|
2022
Q1 | $20.8M | Sell |
236,862
-10,510
| -4% | -$910K | 0.03% | 290 |
|
|
2021
Q4 | $21.6M | Sell |
247,372
-56,933
| -19% | -$4.73M | 0.03% | 288 |
|
|
2021
Q3 | $24.9M | Sell |
304,305
-19,316
| -6% | -$1.74M | 0.05% | 250 |
|
|
2021
Q2 | $29.5M | Buy |
323,621
+19,444
| +6% | +$1.73M | 0.06% | 228 |
|
|
2021
Q1 | $26M | Buy |
304,177
+8,606
| +3% | +$772K | 0.05% | 242 |
|
|
2020
Q4 | $27.9M | Buy |
295,571
+7,536
| +3% | +$659K | 0.06% | 223 |
|
|
2020
Q3 | $25M | Sell |
288,035
-27,503
| -9% | -$2.38M | 0.06% | 229 |
|
|
2020
Q2 | $27.6M | Sell |
315,538
-5,505
| -2% | -$475K | 0.07% | 203 |
|
|
2020
Q1 | $26.5M | Buy |
321,043
+78,210
| +32% | +$6.98M | 0.08% | 192 |
|
|
2019
Q4 | $23M | Buy |
242,833
+4,910
| +2% | +$441K | 0.06% | 234 |
|
|
2019
Q3 | $20.7M | Buy |
237,923
+41,876
| +21% | +$3.76M | 0.06% | 249 |
|
|
2019
Q2 | $17.9M | Sell |
196,047
-57,170
| -23% | -$4.84M | 0.05% | 274 |
|
|
2019
Q1 | $21.8M | Sell |
253,217
-74,807
| -23% | -$6.01M | 0.06% | 235 |
|
|
2018
Q4 | $25.2M | Buy |
328,024
+50,705
| +18% | +$3.95M | 0.08% | 197 |
|
|
2018
Q3 | $21.4M | Buy |
277,319
+32,196
| +13% | +$2.38M | 0.06% | 235 |
|
|
2018
Q2 | $16.6M | Buy |
245,123
+13,402
| +6% | +$925K | 0.05% | 270 |
|
|
2018
Q1 | $16.8M | Sell |
231,721
-36,131
| -13% | -$2.75M | 0.05% | 265 |
|
|
2017
Q4 | $20.2M | Buy |
267,852
+23,188
| +9% | +$1.75M | 0.06% | 241 |
|
|
2017
Q3 | $18.8M | Sell |
244,664
-7,060
| -3% | -$533K | 0.06% | 247 |
|
|
2017
Q2 | $18.8M | Sell |
251,724
-98,034
| -28% | -$6.95M | 0.06% | 242 |
|
|
2017
Q1 | $23.3M | Sell |
349,758
-9,286
| -3% | -$619K | 0.08% | 202 |
|
|
2016
Q4 | $23.4M | Buy |
359,044
+28,689
| +9% | +$1.86M | 0.08% | 193 |
|
|
2016
Q3 | $23.4M | Buy |
330,355
+47,465
| +17% | +$3.46M | 0.09% | 196 |
|
|
2016
Q2 | $20.9M | Sell |
282,890
-31,330
| -10% | -$2.16M | 0.08% | 204 |
|
|
2016
Q1 | $20.4M | Sell |
314,220
-61,061
| -16% | -$4.15M | 0.08% | 206 |
|
|
2015
Q4 | $28.9M | Sell |
375,281
-17,574
| -4% | -$1.4M | 0.12% | 161 |
|
|
2015
Q3 | $32.4M | Sell |
392,855
-9,725
| -2% | -$866K | 0.14% | 147 |
|
|
2015
Q2 | $35.5M | Buy |
402,580
+3,911
| +1% | +$359K | 0.14% | 146 |
|
|
2015
Q1 | $35.2M | Sell |
398,669
-7,555
| -2% | -$670K | 0.14% | 142 |
|
|
2014
Q4 | $33.7M | Buy |
406,224
+29,584
| +8% | +$2.45M | 0.13% | 145 |
|
|
2014
Q3 | $31.8M | Buy |
376,640
+29,234
| +8% | +$2.37M | 0.13% | 143 |
|
|
2014
Q2 | $28.2M | Buy |
347,406
+24,102
| +7% | +$1.9M | 0.11% | 161 |
|
|
2014
Q1 | $24.6M | Buy |
323,304
+9,784
| +3% | +$713K | 0.1% | 171 |
|
|
2013
Q4 | $22.6M | Buy |
313,520
+16,721
| +6% | +$1.16M | 0.09% | 178 |
|
|
2013
Q3 | $20.4M | Sell |
296,799
-11,194
| -4% | -$741K | 0.09% | 172 |
|
|
2013
Q2 | $19.5M | Buy |
+307,993
| New | +$20M | 0.09% | 174 |
|
Other funds holding NVS
US Bancorp's NVS Position: Q2 2026 in Review
US Bancorp reduced its Novartis (NVS) stake by 2.5% in Q2 2026, selling an estimated $1M and leaving 262,178 shares worth $41.1M. The position accounts for 0.04% of the portfolio, ranked #225.
US Bancorp first reported a position in NVS in Q2 2013 and has held it in 53 quarters since. 1,611 funds tracked by Wall St. Rank hold NVS as of Q2 2026.
- US Bancorp held 262,178 shares of Novartis worth $41.1M as of Q2 2026.
- US Bancorp sold 6,680 Novartis shares in Q2 2026, an estimated $1M.
- Novartis made up 0.04% of US Bancorp's portfolio in Q2 2026, its #225 holding.
- US Bancorp first reported a position in Novartis in Q2 2013 and has held it in 53 quarters since.
- 1,611 funds tracked by Wall St. Rank held Novartis as of Q2 2026.
Based on US Bancorp's 13F filing for Q2 2026, filed 12 Aug 2026.